Axsome stock tumbled Tuesday after Axsome Therapeutics issued mixed results for its drug, Sunosi, in ADHD treatment.

IBD 50 stock Enova International is holding up in a base. That shows that its uptrend is still intact for now amid the tariff ...

The IBD 50 has enjoyed a long stretch of terrific returns but the ETF based on it has struggled since its launch. The IBD 50 has enjoyed a long stretch of terrific returns but the ETF based on it ...

Gold is red-hot. This gold ETF has outperformed the S&P 500 by a wide margin over the past year. State Street's gold funds attract $5.4 billion in 2025 inflows as investors seek shelter from ...

Explore the promising results of haematopoietic stem cell transplantation as a treatment for early-onset inflammatory bowel ...

Inflammatory bowel disease (IBD) during pregnancy can lead to complications for individuals who are pregnant and the fetus. Timing conception during remission and preventing or managing flare-ups ...

Managing IBD, a chronic illness, can lead to burnout. Maybe you’re just plain tired of the treatment. Here’s how you can bounce back. If you have Crohn’s disease or ulcerative colitis, you ...

Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education.

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.